Silicon Valley’s Secondary Markets Are Bigger Than Ever
Secondary transactions in venture-backed startups are set to reach new heights in 2024, driven by companies like OpenAI and SpaceX…
Italian life sciences firm XGEN Venture closes debut fund
XGEN Venture, a Milan-based life sciences venture capital firm, has closed its inaugural fund at approximately €180 million, having aimed…
Wunderdogs Unveils Report on the Next Generation of Climate Tech Startups, in Collaboration with True Ventures, Wireframe Ventures, Planeteer Capital, Activate and Prelude Ventures
Wunderdogs, a brand consultancy and digital studio, has released the “Climate Compass” report, detailing the next generation of climate tech…
‘Very, very strong year for both IPOs and M&A’ seen by NPM’s Callahan
Tom Callahan, CEO of Nasdaq Private Market, predicts a significant increase in liquidity events for venture firms in 2025, driven…
Taconic Exits Commercial Real Estate, Unit Head to Join Axonic
Taconic Capital Advisors is winding down its commercial real estate (CRE) operations and is negotiating to sell one of its…
European PE exits in 2024: IPO rebound, LP pressure, secondary sales drive activity
European private equity exits saw a resurgence in 2024, marked by a 5% increase to €14.1 billion in the first…
Behind the VC reset and what’s next in 2025
India’s venture capital (VC) ecosystem remains cautious, retaining significant cash reserves while being pressured for better returns. In 2024, VC…
Athera Venture Partners: Athera Venture Partners HDFC AMC backing for Rs 900-crore Fund-IV
Athera Venture Partners, a technology-focused early-stage investor, has secured capital commitment from HDFC Asset Management Company for its fourth fund,…
India venture capital: VC firms sit on a pile of cash but wary of backing startups
India’s venture capital (VC) landscape is exercising caution in funding startups despite an increase in capital raised—$2.5 billion in 2024…
Pfizer’s In-Line Guidance Offers Relief to Weary Investors
Lee Brown, healthcare sector lead at Third Bridge, discussed Pfizer’s outlook during an interview on BNN Bloomberg. Pfizer forecasts 2025…